While it remains unclear whether Iran is onboard, a US source says the two countries have reached a tentative deal to extend a ceasefire as peace negotiations continue . The prospect comes as both sides renewed fighting in recent days, exchanging fire around the Strait of Hormuz as Israel intensified its invasion of Lebanon and bombing raids there. President Donald Trump (who yesterday threatened ...
While it remains unclear whether Iran is onboard, a US source says the two countries have reached a tentative deal to extend a ceasefire as peace negotiations continue . The prospect comes as both sides renewed fighting in recent days, exchanging fire around the Strait of Hormuz as Israel intensified its invasion of Lebanon and bombing raids there. President Donald Trump (who yesterday threatened to attack US ally Oman ) also has yet to sign off on the proposal, which was first reported by Axios . The interim accord would allow a 60-day extension of the ceasefire and restart negotiations on Iran’s nuclear program, the outlet reported earlier. Over the past month, repeated claims of progress by the White House and more recently Iran were subsequently denied by the other side. But there are significant incentives to avoid further conflict, particularly for the Pentagon: A new study warned US defense contractors will need three years to replace critical weapons expended in the war . What You Need to Know Today Why Wall Street Says a Peace Deal May Happen This Time Two signs suggest “a significant probability” the US and Iran may reach an agreement, Citadel Securities says. Jaded investors could miss out on a huge relief rally if they don’t pay attention. Read more US inflation continued to accelerate last month as economic growth slowed more than expected, according to data released by the Trump administration. Lower spending numbers may suggest consumers are becoming more cautious amid affordability worries and a flattening labor market. The surge in prices for fuel and other materials sparked by the US-Israel war with Iran has driven consumer sentiment to record lows . While oil prices have come down this week, Brent futures remain more than 30% higher than before the war began. Another government report Thursday showed unemployment rising , though the data indicated overall employment appeared resilient in the face of recent mass terminations by technology and finan...
For most of the 16 years since the end of the global financial crisis, the U.S. stock market has been perhaps the best place to invest. American companies from Silicon Valley to Wall Street have generated high profits, fast growth, and strong returns. America's democracy, rule of law, leadership in science and innovation, and strong independent institutions like the Federal Reserve have created an...
For most of the 16 years since the end of the global financial crisis, the U.S. stock market has been perhaps the best place to invest. American companies from Silicon Valley to Wall Street have generated high profits, fast growth, and strong returns. America's democracy, rule of law, leadership in science and innovation, and strong independent institutions like the Federal Reserve have created an investor-friendly climate. And people from around the world have wanted to send their money to America. Investors in U.S.-allied countries like Japan and Canada have bought significant amounts of U.S. stocks and bonds. U.S. stocks have generally outperformed the rest of the world's. This trend in markets has been called "U.S. exceptionalism." You can see it by looking at the past 15 years of S&P 500 index returns vs. the returns of the Vanguard Total International Stock ETF (VXUS +0.16%): But America's investor-preferred status could be facing new threats. Fidelity research published in April says the U.S. exceptionalism narrative might have peaked. Let's look at why the end of U.S. exceptionalism might be coming soon -- and why international stocks could be a better buy today. What the end of U.S. exceptionalism could mean for investors Fidelity research found that in 2025, America had a record-high "international investment deficit" of more than $25 trillion. That means the amount that other countries had invested in America was $25 trillion more than the amount America had invested in other countries. The biggest foreign holders of U.S. long-term securities are Europe ($17.3 trillion), Canada ($3.1 trillion), Japan ($3.0 trillion), and China ($1.2 trillion). What if those trillions of dollars of foreign capital inflows start to flow away from America? That could mean a weaker U.S. dollar. It could mean a decline in U.S. stock markets or slower growth for U.S. stocks than for international stocks. This doesn't mean that America is doomed. The rest of the world can grow a...
Treasury Appointees Push To Put Trump's Face On A Brand-New $250 Bill Two political appointees at the Treasury Department spent months pressing Bureau of Engraving and Printing staff to develop prototypes for a $250 bill bearing Donald Trump's portrait , even as bureau officials repeatedly warned them the project had no legal foundation and could take nearly a decade to execute properly, the Washi...
Treasury Appointees Push To Put Trump's Face On A Brand-New $250 Bill Two political appointees at the Treasury Department spent months pressing Bureau of Engraving and Printing staff to develop prototypes for a $250 bill bearing Donald Trump's portrait , even as bureau officials repeatedly warned them the project had no legal foundation and could take nearly a decade to execute properly, the Washington Post reports. U.S. Treasurer Brandon Beach and senior adviser Mike Brown, both political appointees, began pushing bureau staff last year to prepare designs for the note. Beach handed over mock-up materials in August and September, including a design placing Trump's face at the center of the bill, flanked by Trump's and Treasury Secretary Scott Bessent's signatures. The effort would mark the first time a living person appeared on U.S. currency since 1866, and current employees, speaking anonymously out of fear of retaliation, claim the internal pressure was real. The artist behind the designs, British painter Iain Alexander, said he discussed the project directly with Trump and received feedback on specifics. "He likes to call me his favorite British artist," Alexander said. Trump reportedly pushed for American flag colors and a "250" logo tied to the nation's semiquincentennial, and Alexander said Trump "absolutely loved" the proposed reverse side of the note, which would feature a women's liberation theme with Betsy Ross. Bureau director Patricia "Patty" Solimene, a 24-year Army veteran and the first woman to lead the bureau, told Beach and Brown plainly that the project was unauthorized. One employee described her position this way: "She had told them we're not authorized to do this. We can't progress any further, and all the stakeholders have not even met to discuss the next steps." The same employee noted that "currency often takes six to eight years to produce a new bill, particularly one of such high value." Solimene was reassigned from her position on April 27...
Key Points Fidelity research says that the investor narrative of “U.S. exceptionalism” might have reached a peak. The iShares Core MSCI Total International Stock ETF offers exposure to more than 4,000 global stocks and has delivered 17.7% annualized returns for the past three years. 10 stocks we like better than iShares Trust - iShares Core Msci Total International Stock ETF › For most of the 16 y...
Key Points Fidelity research says that the investor narrative of “U.S. exceptionalism” might have reached a peak. The iShares Core MSCI Total International Stock ETF offers exposure to more than 4,000 global stocks and has delivered 17.7% annualized returns for the past three years. 10 stocks we like better than iShares Trust - iShares Core Msci Total International Stock ETF › For most of the 16 years since the end of the global financial crisis, the U.S. stock market has been perhaps the best place to invest. American companies from Silicon Valley to Wall Street have generated high profits, fast growth, and strong returns. America's democracy, rule of law, leadership in science and innovation, and strong independent institutions like the Federal Reserve have created an investor-friendly climate. And people from around the world have wanted to send their money to America. Investors in U.S.-allied countries like Japan and Canada have bought significant amounts of U.S. stocks and bonds. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » U.S. stocks have generally outperformed the rest of the world's. This trend in markets has been called "U.S. exceptionalism." You can see it by looking at the past 15 years of S&P 500 index returns vs. the returns of the Vanguard Total International Stock ETF (NASDAQ: VXUS): But America's investor-preferred status could be facing new threats. Fidelity research published in April says the U.S. exceptionalism narrative might have peaked. Let's look at why the end of U.S. exceptionalism might be coming soon -- and why international stocks could be a better buy today. What the end of U.S. exceptionalism could mean for investors Fidelity research found that in 2025, America had a record-high "international investment deficit" of more than $25 trillion. That means the amount ...
Key Points Rising inflation can be problematic for the stock market as it may lead to an increase in interest rates. Consumer sentiment has also been declining, highlighting the economy's current struggles. Reducing risk could be paramount for investors given the stock market's strong rally in recent years. 10 stocks we like better than S&P 500 Index › The S&P 500 (SNPINDEX: ^GSPC) struggled in th...
Key Points Rising inflation can be problematic for the stock market as it may lead to an increase in interest rates. Consumer sentiment has also been declining, highlighting the economy's current struggles. Reducing risk could be paramount for investors given the stock market's strong rally in recent years. 10 stocks we like better than S&P 500 Index › The S&P 500 (SNPINDEX: ^GSPC) struggled in the early part of 2026 but has gone on to rally in recent months. It's up close to 11% thus far, and even if it maintained such a gain through to the end of the year, it would perform better than its historical average of 10%. If that happens, it will mark a fourth consecutive year where the S&P 500 has generated above-average returns. But a lot hinges on how the economy is doing, or at least, how investors view things. And a lot of that is going to depend on economic data, such as inflation. On Thursday, the latest inflation numbers came out, and they weren't good, hitting their highest levels since late 2023. Here's why this could be a problem for the market. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Inflation rose to 3.8% for April A key number the Federal Reserve typically considers when making monetary policy decisions is the Personal Consumption Expenditures (PCE) inflation rate, which covers a broader range of expenditures than the Consumer Price Index (CPI). Data released on Thursday showed that in April, the PCE inflation rate was 3.8%, up from 3.5% in March. And Core PCE, which excludes food and energy, was 3.3% -- the highest it's been since November 2023. Back then, inflation was on the way down, however, and investor sentiment was improving. Today, things are much different as consumers are more concerned about rising costs. Consumer sentiment hit a record low in May, falling even below l...
Image source: The Motley Fool. Thursday, May 28, 2026 at 4:30 p.m. ET Call participants Chief Executive Officer and President — Mark Marron Chief Operating Officer and President, ePlus Technology — Darren S. Raiguel Chief Financial Officer — Elaine D. Marion General Counsel — Erica S. Stoecker Senior Vice President — Kleyton L. Parkhurst Need a quote from a Motley Fool analyst? Email [email protec...
Image source: The Motley Fool. Thursday, May 28, 2026 at 4:30 p.m. ET Call participants Chief Executive Officer and President — Mark Marron Chief Operating Officer and President, ePlus Technology — Darren S. Raiguel Chief Financial Officer — Elaine D. Marion General Counsel — Erica S. Stoecker Senior Vice President — Kleyton L. Parkhurst Need a quote from a Motley Fool analyst? Email [email protected] Takeaways Gross billings -- Reached a record $3.8 billion, increasing 17% and underscoring broad customer demand across strategic focus areas. -- Reached a record $3.8 billion, increasing 17% and underscoring broad customer demand across strategic focus areas. Net sales -- Increased 20.6% to $576.2 million in the quarter, with full-year net sales up 22.1% to $2.4 billion. -- Increased 20.6% to $576.2 million in the quarter, with full-year net sales up 22.1% to $2.4 billion. Product revenue -- Rose 25% to $466.2 million in the quarter, with annual product sales advancing 23.7% to nearly $2 billion. -- Rose 25% to $466.2 million in the quarter, with annual product sales advancing 23.7% to nearly $2 billion. Services revenue -- Increased 4.9% to $110 million in the quarter and 15.6% for the year, driven by both professional and managed services. -- Increased 4.9% to $110 million in the quarter and 15.6% for the year, driven by both professional and managed services. Managed services revenue -- Grew 9.3% in the quarter to $48.7 million and approximately 11% for the year, as new offerings and customer wins contributed to the portfolio. -- Grew 9.3% in the quarter to $48.7 million and approximately 11% for the year, as new offerings and customer wins contributed to the portfolio. Professional services revenue -- Increased to $61.3 million for the quarter, with annual growth of 19%, reflecting the addition of Bailiwick services and timing delays in retail projects. -- Increased to $61.3 million for the quarter, with annual growth of 19%, reflecting the addition of Bailiwick s...
昂坪360嚴查冒牌職員、打擊黃牛 增告示加派人手防旅客上當 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】因應有人在昂坪360纜車站附近，模仿職員打扮兜售門票，昂坪360即日起在車站增設大型告示，並加派人手指示旅...
昂坪360嚴查冒牌職員、打擊黃牛 增告示加派人手防旅客上當 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】因應有人在昂坪360纜車站附近，模仿職員打扮兜售門票，昂坪360即日起在車站增設大型告示，並加派人手指示旅客購票，防止旅客遭誤導，並會聯同政府部門打擊。 早上昂坪360未開放，在東涌港鐵站往纜車站途中，已有兩人坐在路邊，都是身穿綠色衫，近似纜車職員的制服。之後拖著手拉車在路邊徘徊，及後有職員到場驅趕他們。 早在五一勞動節，都有相同打扮的人在纜車站正門擺放攤位，懷疑兜售纜車門票。昂坪360已在出入口增設大型告示，提醒旅客不要光顧這些攤檔，必須經官方渠道購票，否則不可上車。又派職員指示旅客前往售票處。 印尼旅客Martin：「如果你不是在售票處購買門票，可能會被騙，人們不太熟悉這裡。」市民張先生：「看到一些非法拉車客，通常都不會理會，這方面的意識強，不會隨便，就算有人叫我買票，都不會理會，直接離開，通常提前用信用卡在網上購票，或者現場購票。」 昂坪360提醒，門票不得轉售，會持續監察情況，並與政府部門合作打擊。昂坪360亦加派人手，在乘客進入車站前，先核對車票的來源，上車前再用閘機檢驗。
Never miss an episode. Follow The Big Take daily podcast today. Free speech lawyers are watching in real time as the US government escalates efforts to unmask anonymous critics of ICE. On today’s Big Take podcast, Justice Department reporter Jimmy Jenkins and legal reporter Zoe Tillman join host David Gura to break down their exclusive reporting on how the DOJ is deploying an old legal tool in a n...
Never miss an episode. Follow The Big Take daily podcast today. Free speech lawyers are watching in real time as the US government escalates efforts to unmask anonymous critics of ICE. On today’s Big Take podcast, Justice Department reporter Jimmy Jenkins and legal reporter Zoe Tillman join host David Gura to break down their exclusive reporting on how the DOJ is deploying an old legal tool in a novel way. We’ll hear from an attorney defending one of the users and explore what the new strategy means for social media platforms, online anonymity and First Amendment freedoms. Read more: The DOJ Wants to Know Who on Reddit and X Is Criticizing ICE's Tactics We have a special Bloomberg subscription offer for podcast listeners at Bloomberg.com/podcastoffer. Listen and follow The Big Take on Apple Podcasts , Spotify or wherever you get your podcasts. Terminal clients: Visit NSUB to subscribe. This episode was produced by: Julia Press; Editors: Jeffrey Grocott; Fact-checker: Rachael Lewis-Krisky and Laura Newcombe; Sound Design/Engineer: Alex Sugiura; Senior Producer: Naomi Shavin; Senior Editor: Elisabeth Ponsot; Deputy Executive Producer: Julia Weaver; Executive Producer: Nicole Beemsterboer.
Alexander Sikov Apollo Global Management ( APO ) and Blackstone ( BX ) are pitching investors on a ~$36B debt financing that will help Anthropic ( ANTHRO ) expand its AI infrastructure, according to a media report on Thursday. The debt will be used to buy Google's ( GOOG ) ( GOOGL ) custom chips, known as TPUs (tensor processing units). Anthropic ( ANTHRO ) will then lease the TPUs, Bloomberg repo...
Alexander Sikov Apollo Global Management ( APO ) and Blackstone ( BX ) are pitching investors on a ~$36B debt financing that will help Anthropic ( ANTHRO ) expand its AI infrastructure, according to a media report on Thursday. The debt will be used to buy Google's ( GOOG ) ( GOOGL ) custom chips, known as TPUs (tensor processing units). Anthropic ( ANTHRO ) will then lease the TPUs, Bloomberg reported, citing people familiar with the matter. Broadcom ( AVGO ), which is helping to develop the chips, is backstopping payments on the largest parts of the deal, the people said. The debt syndication is private, meaning only investors invited into the deal can participate. Apollo ( APO ) and Blackstone ( BX ) plan to sell down some debt while still holding on to a significant amount, Bloomberg reported, citing the people. More on Apollo Global, Anthropic Apollo Global Management, Inc. (APO) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript Wall Street Lunch: First Step To AI Getting An Oscar Alphabet: The Outperformance Opportunity Has Moved To A New Mag 7 Company Chatbot wars: OpenAI growth slows but still leads rivals in total usage, says Sensor Tower Anthropic surpasses OpenAI as most valuable AI startup after raising $65B
What Happened? Shares of enterprise software giant Oracle (NYSE:ORCL) jumped 6.9% in the afternoon session after Snowflake's impressive earnings results provided the clearer evidence that the "SaaSpocalypse" — a rolling selloff that had erased approximately $2 trillion from software market values since late 2025 on fears that AI would make subscription software obsolete — had been overstated for p...
What Happened? Shares of enterprise software giant Oracle (NYSE:ORCL) jumped 6.9% in the afternoon session after Snowflake's impressive earnings results provided the clearer evidence that the "SaaSpocalypse" — a rolling selloff that had erased approximately $2 trillion from software market values since late 2025 on fears that AI would make subscription software obsolete — had been overstated for platforms sitting at the centre of AI workflows. Snowflake surged 35%, its best single day ever, after reporting that AI accounts on its platform jumped from 9,100 to 13,600 in a single quarter, product revenue grew 34%, and full-year guidance was raised by $180 million. The read-through was immediate. ServiceNow gained 5%, Palantir rose nearly 6%, Oracle and Microsoft each added roughly 3%, and a broad wave lifted the iShares Expanded Tech-Software Sector ETF (IGV). The SaaSpocalypse thesis rested on a simple fear: that autonomous AI agents would replace per-seat software licences, hollowing out established SaaS business models. Snowflake's results inverted that logic directly. Instead of AI displacing its platform, AI drove more consumption of it. CFO Brian Robins described Cortex Code as creating a "step function change" in AI revenue potential, and said it was the single largest driver of the full-year guidance raise. Enterprises are not replacing data platforms with AI; they are using AI to generate more workloads that run on those same platforms. After the initial pop, the shares cooled down and closed the day at $203.89, up 6.8% from the previous close. Is now the time to buy Oracle? Access our full analysis report here, it’s free. What Is The Market Telling Us Oracle’s shares are very volatile and have had 29 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 14 days ago whe...
Ondas (NASDAQ:ONDS) , providing private wireless, drone, and automated data solutions, closed Thursday at $13.25, up 22.69%. The stock jumped after news broke that the Trump administration is exploring potential funding deals with an array of drone companies. The news sent the broader drone niche soaring higher today. Trading volume reached 241.6 million shares, about 216% above its three-month av...
Ondas (NASDAQ:ONDS) , providing private wireless, drone, and automated data solutions, closed Thursday at $13.25, up 22.69%. The stock jumped after news broke that the Trump administration is exploring potential funding deals with an array of drone companies. The news sent the broader drone niche soaring higher today. Trading volume reached 241.6 million shares, about 216% above its three-month average of 76.4 million shares. Ondas IPO'd in 2020 and has grown 115% since going public. The S&P 500 added 0.57% to finish Thursday at 7,563, while the Nasdaq Composite gained 0.91% to close at 26,917. Within the drone industry, peers were bullish, as Unusual Machines closed at $29.60 (+57.2%) while AeroVironment finished at $214.39 (+18.3%). Ondas added to its incredible 11-bagging run over just the last year, rising another 23% today. The next-gen drone and autonomous defense platform spiked on news that the Trump administration was weighing funding deals with key players in the drone space. Continue reading
Worthington Steel Inc. raised $1.4 billion in the leveraged-finance market Thursday to help fund its acquisition of German metals company Klöeckner & Co SE . Ohio-based Worthington priced $700 million each of junk bonds and leveraged loans in deals led by Wells Fargo & Co. , according to people familiar with the situation who asked not to be identified as they’re not authorized to speak publicly. ...
Worthington Steel Inc. raised $1.4 billion in the leveraged-finance market Thursday to help fund its acquisition of German metals company Klöeckner & Co SE . Ohio-based Worthington priced $700 million each of junk bonds and leveraged loans in deals led by Wells Fargo & Co. , according to people familiar with the situation who asked not to be identified as they’re not authorized to speak publicly. The initial plan was for a $900 million note and a $500 million loan. The seven-year bond has a yield of 7.75%, versus price talk of about 8.25%, one person said. The loan has a margin 4 percentage points above benchmark and was issued at 98.5 cents on the dollar, another person said. It was initially offered at 98 cents. Investors have been hungry for new money offerings at a time when most transactions of late have been to refinance or reprice existing debt. As of May 22, just 3% of this month’s leveraged-loan deals by dollar amount were for acquisitions or buyouts, according to data compiled by Bloomberg. Worthington reached an agreement in January to acquire Klöeckner in a deal valued at $2.4 billion. The transaction is expected to close on June 3, Worthington said on Wednesday.
Saulo Angelo/iStock via Getty Images The World Health Organization has given the green light to examine Regeneron Pharmaceuticals' ( REGN ) antibody maftivimab as a potential treatment for the current Ebola outbreak. Maftivimab is one of the antibodies included in the company's US FDA-approved Inmazeb (maftivimab, atoltivimab, and odesivimab), which is used for the Orthoebolavirus zairense species...
Saulo Angelo/iStock via Getty Images The World Health Organization has given the green light to examine Regeneron Pharmaceuticals' ( REGN ) antibody maftivimab as a potential treatment for the current Ebola outbreak. Maftivimab is one of the antibodies included in the company's US FDA-approved Inmazeb (maftivimab, atoltivimab, and odesivimab), which is used for the Orthoebolavirus zairense species of Ebola. The WHO's Therapeutics Advisory Group said that maftivimab should be prioritized for the Bundibugyo ebolavirus species, which is responsible for the outbreak in the Democratic Republic of the Congo and Uganda. The body said that Gilead Sciences' ( GILD ) antiviral remdesivir, approved as a COVID-19 therapy, should also be evaluated, as well as its experimental obeldesivir for post-exposure prophylaxis. Merck ( MRK ) makes Ervebo, currently the only licensed Ebola vaccine. However, it is approved for Ebola caused by viruses in the Orthoebolavirus family. " WHO recommends that Ervebo should not be used outside carefully designed research settings, to allow for its performance against [ Bundibugyo ebolavirus ] to be assessed." More on Regeneron Pharmaceuticals Regeneron: Time To Forget Fianlimab (Rating Upgrade) Regeneron Pharmaceuticals, Inc. (REGN) Presents at Bank of America Global Healthcare Conference 2026 Transcript Regeneron Pharmaceuticals, Inc. (REGN) Q1 2026 Earnings Call Transcript Chip stocks lead Nasdaq's gainers this week; Intuit plunges most after Q3 print Regeneron backed Parabilis Medicines seeks U.S. IPO
Earnings Call Insights: Hormel Foods (HRL) Q2 2026 Management view “We delivered an excellent second quarter, highlighted by continued top line momentum and meaningful improvement in bottom line performance,” said (Interim CEO & Director Jeffrey Ettinger), emphasizing “our sixth consecutive quarter of organic net sales growth” and “impressive double-digit adjusted earnings growth,” with benefits f...
Earnings Call Insights: Hormel Foods (HRL) Q2 2026 Management view “We delivered an excellent second quarter, highlighted by continued top line momentum and meaningful improvement in bottom line performance,” said (Interim CEO & Director Jeffrey Ettinger), emphasizing “our sixth consecutive quarter of organic net sales growth” and “impressive double-digit adjusted earnings growth,” with benefits from “margin expansion, improved manufacturing performance and solid results from our joint ventures, which more than offset higher logistics expenses.” (Interim CEO & Director Jeffrey Ettinger) said management is “reaffirming our organic net sales and adjusted earnings per share expectations,” adding, “we believe we are trending toward the upper half of our earnings range,” while also flagging that “we now see third quarter adjusted earnings to be more in line with the prior year” due to “near-term cost pressures” and “actions to rebalance some inventory levels.” (President & Director John Ghingo) framed demand conditions as pressured but resilient: “While consumers are under pressure and sentiment is low, food has remained resilient in recent months, particularly with growth in protein,” and highlighted segment performance including Foodservice “organic net sales growth of 7%,” International “organic net sales up 5%,” and Retail “1% organic net sales growth, margin expansion and 13% segment profit growth.” (Interim CFO & Controller Paul Kuehneman) said, “gross margin expanded to 17.4%, up 70 basis points,” “adjusted earnings per share was $0.40, up 14%,” and described the portfolio-shaping move: “We completed an important strategic transaction in the quarter, closing on the divestiture of our whole-bird turkey business,” adding, “We recorded a loss on the transaction reflected in SG&A.” Outlook (Interim CFO & Controller Paul Kuehneman) said Hormel is “reaffirming our full year net sales expectations of $12.2 billion to $12.5 billion and our full year adjusted earnings per ...
Getty Images Overview - Brief History Of Personalis Fremont, California-based Personalis, Inc. ( PSNL ) completed its Initial Public Offering ("IPO") in June 2019, raising ~$135m via the issuance of ~7.92m shares priced at $17 per share. In a press release , the company described itself as: a growing cancer genomics company transforming the development of next-generation therapies by providing mor...
Getty Images Overview - Brief History Of Personalis Fremont, California-based Personalis, Inc. ( PSNL ) completed its Initial Public Offering ("IPO") in June 2019, raising ~$135m via the issuance of ~7.92m shares priced at $17 per share. In a press release , the company described itself as: a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. Despite posting some promising early revenue numbers, reliance on a single client—the Veterans Affairs Million Veteran Program ("VA MVP")—and mounting losses meant that by Feb. 2023, Personalis stock traded at ~$4 per share, and only after gaining on news of a partnership struck with the pharmas Moderna ( MRNA ) and Merck ( MRK ) to assist in the development of their "cancer vaccine" MRNA-4157, indicated for melanoma, by providing testing services. By the end of 2023, shares had dropped to ~$1 in value, as Personalis announced it would cut 65 staff to cut costs and extend its funding runway into 2026. The company filed for a $200m mixed shelf offering shortly after. In its 2025 annual report/ 10-K filing , Personalis provides a business description as follows: Our testing services are used by physicians to detect residual or recurrent cancer in patients, monitor cancer response to therapy, and uncover insights for therapy selection. Our testing services are used by pharmaceutical companies for translational research, biomarker discovery, the development of personalized cancer therapies, and clinical trials. We also provide whole exome sequencing services for other diagnostic companies and whole genome sequencing services for population sequencing initiatives. We perform our testing services in a large-scale, high-quality, Clinical Laboratory Improvement Amendments of 1988 ("CLIA") certified and College of American Pathologists (“CAP”) accredited, laboratory located in our 100,000 square foot hea...
Justin Sullivan/Getty Images News Gap ( GAP ) shares fell sharply in after-hours trading as softer comparable sales at Old Navy and Banana Republic, combined with reduced fiscal-year sales guidance, offset strong double-digit comparable sales growth at the flagship Gap brand, its best performance in over 20 years. Comparable store sales at Old Navy were up just 1% in Q1 vs. 2.88% estimates; Banana...
Justin Sullivan/Getty Images News Gap ( GAP ) shares fell sharply in after-hours trading as softer comparable sales at Old Navy and Banana Republic, combined with reduced fiscal-year sales guidance, offset strong double-digit comparable sales growth at the flagship Gap brand, its best performance in over 20 years. Comparable store sales at Old Navy were up just 1% in Q1 vs. 2.88% estimates; Banana Republic comparable sales rose 2% versus 4.26% estimates, while Gap outperformed with comparable sales increasing 10%, exceeding 5.5% estimates. The combination of the three resulting in overall comparable store sales of +2%, less than 2.93% estimates. Net sales were up 1% year-over-year to a below-consensus $3.5B as modest gains for Old Navy, Gap, and Banana Republic were undermined by a 12% drop in sales for the company’s struggling Athleta brand. The company’s margins were mixed, as a gross margin of 40.5% was above 40.3% estimates, but an adjusted operating margin of 5.2% missed 6.1% expectations. Gap’s ( GAP ) FY26 outlook “reflects a balanced approach, factoring in favorability from updated tariff assumptions while taking into consideration potential uncertainties in the operating environment over the balance of the year.” Accordingly, Gap ( GAP ) raised its profit outlook to be within a range of $2.30 to $2.40 per share versus $2.32 estimates. This compares to the prior range of $2.20 and $2.35 per share. The outlook for net sales, however, has been lowered, with the company now expecting sales to be up 1% to 2% compared to the earlier forecast for growth of 2% to 3%. This translates into a range of $15.55B and $15.71B, less than the $15.74B estimates. The company maintained its other estimates, with gross margin expected to be flat to up slightly from the previous year and adjusted operating margin between 7.3% and 7.5% versus 7.3% in FY25. More on Gap The Gap: Margin Improvement Faces Slow Growth Outlook The Gap: Despite Holiday Sales Miss, 2026 Is Positioned For ...